Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART

• Paul W. Denton,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Julie M. Long,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Stephen W. Wietgrefe,

  Affiliation Department of Microbiology, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Craig Sykes,

  Affiliation Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Rae Ann Spagnuolo,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Olivia D. Snyder,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Katherine Perkey,

  Affiliation Department of Microbiology, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Nancie M. Archin,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Shailesh K. Choudhary,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Kuo Yang,

  Affiliation Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Michael G. Hudgens,

  Affiliation Department of Biostatistics, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Ira Pastan,

  Affiliation Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Ashley T. Haase,

  Affiliation Department of Microbiology, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Angela D. Kashuba,

  Affiliation Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Edward A. Berger,

  Affiliation Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• David M. Margolis,

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
•  [ ... ],
• J. Victor Garcia

  * E-mail: victor_garcia@med.unc.edu

  Affiliation Division of Infectious Diseases, Department of Medicine, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]